Pronostic Value of Type I ANTi-Interferon Antibodies in Patients With COVID-19 Acute Respiratory Failure
CompletedOBSERVATIONAL
Enrollment
1,022
Participants
Timeline
Start Date
November 20, 2020
Primary Completion Date
June 30, 2021
Study Completion Date
October 30, 2021
Conditions
Acute Respiratory Failure
Trial Locations (1)
94010
Assistance Publique Hôpitaux de Paris - CHU HENRI MONDOR, Créteil
All Listed Sponsors
lead
Assistance Publique - Hôpitaux de Paris
OTHER
NCT04733105 - Pronostic Value of Type I ANTi-Interferon Antibodies in Patients With COVID-19 Acute Respiratory Failure | Biotech Hunter | Biotech Hunter